Health and Social Care secretary Matt Hancock has announced that £1 billion of funding will go to as many as 75 projects across England to upgrade facilities and treat more patients, including mental health and new integrated care services in the community.
The Prescription Medicines Code of Practice Authority (PMCPA) has announced that Astellas, Sunovion and Shield Therapeutics have all breached the Association of the British Pharmaceutical Industry's Code of Practice.
Excitement around the transformative potential of AI and machine learning continues to build. Companies will need to adapt their individual offers to draw in AI specialists, but as an industry UK pharma should also continue to champion itself and the unique career advantages it holds for the best and brightest researchers.
Professor Chris Whitty, chief scientific adviser for the Department of Health and Social Care (DHSC), on the role of the NIHR and the promise of the government's second sector deal for the life sciences industry.
There are around 7,000 rare diseases for which there currently exists no authorised or satisfactory method of treatment, highlighting a vast area of unmet need, and yet the clinical development of orphan drugs is still fraught with many practical challenges.